dc.creator | Taborga L. | |
dc.creator | Sortino M. | |
dc.creator | Carrasco H. | |
dc.creator | Butassi E. | |
dc.creator | Zacchino S. | |
dc.creator | Espinoza L. | |
dc.date.accessioned | 2020-09-02T22:29:19Z | |
dc.date.accessioned | 2022-11-08T20:28:34Z | |
dc.date.available | 2020-09-02T22:29:19Z | |
dc.date.available | 2022-11-08T20:28:34Z | |
dc.date.created | 2020-09-02T22:29:19Z | |
dc.date.issued | 2017 | |
dc.identifier | 109, , 827-835 | |
dc.identifier | 02786915 | |
dc.identifier | https://hdl.handle.net/20.500.12728/6415 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5146868 | |
dc.language | en | |
dc.publisher | Elsevier Ltd | |
dc.subject | Antifungal activity | |
dc.subject | Candida albicans | |
dc.subject | Cryptococcus neoformans. | |
dc.subject | Linear geranylphenols | |
dc.subject | 3 (3,7 dimethylocta 2,6 dienyl)benzene 1,2 diol | |
dc.subject | 4 (3,7 dimethylocta 2,6 dienyl) 1,3 phenylene acetoacetic acid | |
dc.subject | 4 (3,7 dimethylocta 2,6 dienyl)benzene 1,2 diol | |
dc.subject | amphotericin B | |
dc.subject | antifungal agent | |
dc.subject | geranylphenol derivative | |
dc.subject | phenol derivative | |
dc.subject | unclassified drug | |
dc.subject | antifungal agent | |
dc.subject | phenol | |
dc.subject | anticryptoccocal activity | |
dc.subject | antifungal activity | |
dc.subject | Article | |
dc.subject | Candida albicans | |
dc.subject | Candida glabrata | |
dc.subject | Candida parapsilosis | |
dc.subject | Candida tropicalis | |
dc.subject | Clavispora lusitaniae | |
dc.subject | controlled study | |
dc.subject | Cryptococcus neoformans | |
dc.subject | cytotoxicity | |
dc.subject | drug activity | |
dc.subject | drug structure | |
dc.subject | fungus isolation | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | IC50 | |
dc.subject | in vitro study | |
dc.subject | MIC100 | |
dc.subject | MIC50 | |
dc.subject | minimum inhibitory concentration | |
dc.subject | nonhuman | |
dc.subject | Pichia kudriavzevii | |
dc.subject | skin fibroblast | |
dc.subject | structure activity relation | |
dc.subject | chemical structure | |
dc.subject | chemistry | |
dc.subject | drug effects | |
dc.subject | microbial sensitivity test | |
dc.subject | Antifungal Agents | |
dc.subject | Candida albicans | |
dc.subject | Cryptococcus neoformans | |
dc.subject | Microbial Sensitivity Tests | |
dc.subject | Molecular Structure | |
dc.subject | Phenol | |
dc.subject | Structure-Activity Relationship | |
dc.title | Antifungal toxicity of linear geranylphenol. Influence of oxigenate substituents | |
dc.type | Article | |